Authors: Weitzman, AL Shelton, G Zuech, N Owen, CE Judge, T Benson, M Sawczuk, I Katz, A Olsson, CA Bagiella, E Pfaff, C Newhouse, JH Petrylak, DP

Citation: Al. Weitzman et al., Dexamethasone does not significantly contribute to the response rate of docetaxel and estramustine in androgen independent prostate cancer, J UROL, 163(3), 2000, pp. 834-837

Authors: Petrylak, DP Macarthur, RB O'Connor, J Shelton, G Judge, T Balog, J Pfaff, C Bagiella, E Heitjan, D Fine, R Zuech, N Sawczuk, I Benson, M Olsson, CA

Citation: Dp. Petrylak et al., Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer, J CL ONCOL, 17(3), 1999, pp. 958-967

Authors: Petrylak, DP Macarthur, R O'Connor, J Shelton, G Weitzman, A Judge, T England-Owen, C Zuech, N Pfaff, C Newhouse, J Bagiella, E Hetjan, D Sawczuk, I Benson, M Olsson, C

Citation: Dp. Petrylak et al., Phase I/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer, SEMIN ONCOL, 26(5), 1999, pp. 28-33